Evolus Inc (NASDAQ:EOLS)
| 8.44 Delayed Data As of Mar 24 |  +0.19 / +2.30%Today’s Change | 6.51 Today|||52-Week Range 14.34 | +12.38% Year-to-Date |
Latest EOLS News | Press Releases
No recent news for Evolus Inc.
Today’s Trading
| Previous close | 8.25 |
| Today’s open | 8.18 |
| Day’s range | 8.18 - 8.47 |
| Volume | 7,550 |
| Average volume (3 months) | 493,614 |
| Market cap | $482.9M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -41.12% |
| Earnings growth (this year) | +50.70% |
| Earnings growth (next 5 years) | +2.75% |
| Revenue growth (last year) | +49.10% |
| P/E ratio | NM |
| Price/Sales | 2.83 |
| Price/Book | 26.03 |
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $148.6M |
| Annual profit (last year) | -$74.4M |
| Net profit margin | -50.07% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newport Beach, California |
Forecasts
